» Articles » PMID: 24439373

Sphingolipids from a Symbiotic Microbe Regulate Homeostasis of Host Intestinal Natural Killer T Cells

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2014 Jan 21
PMID 24439373
Citations 314
Authors
Affiliations
Soon will be listed here.
Abstract

Coevolution of beneficial microorganisms with the mammalian intestine fundamentally shapes mammalian physiology. Here, we report that the intestinal microbe Bacteroides fragilis modifies the homeostasis of host invariant natural killer T (iNKT) cells by supplementing the host's endogenous lipid antigen milieu with unique inhibitory sphingolipids. The process occurs early in life and effectively impedes iNKT cell proliferation during neonatal development. Consequently, total colonic iNKT cell numbers are restricted into adulthood, and hosts are protected against experimental iNKT cell-mediated, oxazolone-induced colitis. In studies with neonatal mice lacking access to bacterial sphingolipids, we found that treatment with B. fragilis glycosphingolipids-exemplified by an isolated peak (MW = 717.6) called GSL-Bf717-reduces colonic iNKT cell numbers and confers protection against oxazolone-induced colitis in adulthood. Our results suggest that the distinctive inhibitory capacity of GSL-Bf717 and similar molecules may prove useful in the treatment of autoimmune and allergic disorders in which iNKT cell activation is destructive.

Citing Articles

Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis.

Zhao F, Shao M, Li M, Li T, Zheng Y, Sun W Cell Mol Biol Lett. 2025; 30(1):18.

PMID: 39920588 PMC: 11804087. DOI: 10.1186/s11658-024-00679-2.


identified as key strain to alleviate gut barrier injury through Wnt signaling pathway.

Ma X, Li M, Zhang Y, Xu T, Zhou X, Qian M Elife. 2025; 12.

PMID: 39912727 PMC: 11801796. DOI: 10.7554/eLife.92906.


Intestinal permeability, food antigens and the microbiome: a multifaceted perspective.

Valitutti F, Mennini M, Monacelli G, Fagiolari G, Piccirillo M, Di Nardo G Front Allergy. 2025; 5():1505834.

PMID: 39850945 PMC: 11754301. DOI: 10.3389/falgy.2024.1505834.


Exploring gut microbiota as a novel therapeutic target in Crohn's disease: Insights and emerging strategies.

Qiao T, Wen X World J Gastroenterol. 2025; 31(2):100827.

PMID: 39811502 PMC: 11684203. DOI: 10.3748/wjg.v31.i2.100827.


Gut bacterial sphingolipid production modulates dysregulated skin lipid homeostasis.

Lee M, Tan X, Le H, Besler K, Thompson S, Harris-Tryon T bioRxiv. 2025; .

PMID: 39803564 PMC: 11722302. DOI: 10.1101/2024.12.29.629238.


References
1.
Altschul S, Wootton J, Gertz E, Agarwala R, Morgulis A, Schaffer A . Protein database searches using compositionally adjusted substitution matrices. FEBS J. 2005; 272(20):5101-9. PMC: 1343503. DOI: 10.1111/j.1742-4658.2005.04945.x. View

2.
Matangkasombut P, Pichavant M, DeKruyff R, Umetsu D . Natural killer T cells and the regulation of asthma. Mucosal Immunol. 2009; 2(5):383-92. DOI: 10.1038/mi.2009.96. View

3.
Levy Zitomersky N, Coyne M, Comstock L . Longitudinal analysis of the prevalence, maintenance, and IgA response to species of the order Bacteroidales in the human gut. Infect Immun. 2011; 79(5):2012-20. PMC: 3088145. DOI: 10.1128/IAI.01348-10. View

4.
Fuss I, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S . Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest. 2004; 113(10):1490-7. PMC: 406524. DOI: 10.1172/JCI19836. View

5.
Yatsunenko T, Rey F, Manary M, Trehan I, Dominguez-Bello M, Contreras M . Human gut microbiome viewed across age and geography. Nature. 2012; 486(7402):222-7. PMC: 3376388. DOI: 10.1038/nature11053. View